​

RAPT Therapeutics Ownership | Who Owns RAPT Therapeutics?

OverviewForecastFinancialsChart

RAPT Therapeutics Ownership Summary

RAPT Therapeutics is owned by 4.84% institutional investors, 0.28% insiders, and 94.89% retail investors. Blackrock is the largest institutional shareholder, holding 6.32% of RAPT shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.73% of its assets in RAPT Therapeutics shares.

RAPT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRAPT Therapeutics4.84%0.28%94.89%
SectorHealthcare Stocks 232.20%10.74%-142.94%
IndustryBiotech Stocks 382.11%10.55%-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock2.44M6.32%$7.44M
Tcg crossover management1.64M6.07%$42.20M
Foresite capital management vi1.56M5.80%$40.30M
Rtw investments, lp1.47M5.46%$37.92M
Column group1.33M4.93%$10.63B
Vanguard group1.19M4.40%$40.20M
Orbimed advisors1.09M4.03%$28.02M
Boone capital management782.46K2.90%$20.18M
Soleus capital management764.00K2.83%$25.88M
Nantahala capital management754.15K2.80%$25.54M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Column group1.33M16.17%$10.63B
Foresite capital management vi1.56M15.57%$40.30M
Boone capital management782.46K6.62%$20.18M
Tcg crossover management1.64M2.08%$42.20M
Velan capital investment management lp79.98K1.94%$2.06M
Fcpm iii services b.v.344.24K1.77%$8.88M
Ikarian capital615.00K1.60%$15.86M
Redmile group552.59K1.39%$14.25M
Adar1 capital management507.77K1.23%$13.10M
Soleus capital management764.00K0.95%$25.88M

Top Buyers

HolderShares% AssetsChange
Boone capital management782.46K6.62%782.46K
Ikarian capital615.00K1.60%615.00K
Siren580.47K0.59%580.47K
Vanguard group1.19M0.00%490.60K
Blackrock funding, inc. /de486.15K0.00%396.65K

Top Sellers

HolderShares% AssetsChange
Medicxi ventures management (jersey)---2.79M
Bvf inc/il---1.15M
Affinity asset advisors---1.00M
Kingdon capital management---575.00K
Orbimed advisors1.09M0.66%-555.29K

New Positions

HolderShares% AssetsChangeValue
Boone capital management782.46K6.62%782.46K$20.18M
Ikarian capital615.00K1.60%615.00K$15.86M
Siren580.47K0.59%580.47K$14.97M
Boothbay fund management223.86K0.08%223.86K$5.77M
Altium capital management lp200.00K0.25%200.00K$610.00K

Sold Out

HolderChange
Srs capital advisors-1.00
Farther finance advisors-2.00
Advisor group-5.00
Quest partners-5.00
Nelson, van denburg & campbell wealth management group-7.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202512-81.82%1,304,681-90.42%40.19%8-75.76%2-89.47%
Sep 30, 202512-75.51%730,587-95.69%20.07%4-33.33%5-88.10%
Jun 30, 20251-98.90%12,437-99.99%-0.01%--100.00%1-96.15%
Mar 31, 202591-4.21%131,135,9343.35%2430.23%41-33.87%2630.00%
Dec 31, 202490-5.26%114,301,746283.56%2935.01%5750.00%20-25.93%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O2.00M5.73%-
Vanguard Total Stock Mkt Idx Inv670.62K4.06%-18.51K
Fidelity Growth Compy Commingled Pl S2.05M1.56%21.11K
Fidelity Growth Company Fund1.49M1.13%-18.17K
Vanguard US Total Market Shares ETF1.12M0.85%-
Vanguard Institutional Extnd Mkt Idx Tr119.57K0.72%-54.48K
iShares Biotechnology ETF201.44K0.58%-
iShares Russell 2000 ETF703.88K0.53%-
Fidelity Growth Company K6481.38K0.36%-2.94K
Federated Hermes MDT SCC Institutional461.23K0.35%-

Recent Insider Transactions

DateNameRoleActivityValue
Jan 05, 2024Brockstedt Dirk G. CHIEF SCIENTIFIC OFFICERSell$20.46K
Dec 21, 2023HO WILLIAM Chief Medical OfficerSell$54.20K
Nov 28, 2023HO WILLIAM Chief Medical OfficerSell$20.58K
Oct 03, 2023HO WILLIAM Chief Medical OfficerSell$39.42K
Aug 18, 2023HO WILLIAM Chief Medical OfficerSell$47.30K

Insider Transactions Trends

DateBuySell
2024 Q4--
2024 Q2--
2024 Q1-1
2023 Q4-3
2023 Q3-1

RAPT Ownership FAQ

Who Owns RAPT Therapeutics?

RAPT Therapeutics shareholders are primarily institutional investors at 4.84%, followed by 0.28% insiders and 94.88% retail investors. The average institutional ownership in RAPT Therapeutics's industry, Biotech Stocks , is 382.11%, which RAPT Therapeutics falls below.

Who owns the most shares of RAPT Therapeutics?

RAPT Therapeutics’s largest shareholders are Blackrock (2.44M shares, 6.32%), Tcg crossover management (1.64M shares, 6.07%), and Foresite capital management vi (1.56M shares, 5.80%). Together, they hold 18.19% of RAPT Therapeutics’s total shares outstanding.

Does Blackrock own RAPT Therapeutics?

Yes, BlackRock owns 6.32% of RAPT Therapeutics, totaling 2.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.44M$. In the last quarter, BlackRock decreased its holdings by -32.323K shares, a -1.31% change.

Who is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested?

Column group is RAPT Therapeutics’s biggest shareholder by percentage of total assets invested, with 16.17% of its assets in 1.33M RAPT Therapeutics shares, valued at 10.63B$.

Who is the top mutual fund holder of RAPT Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of RAPT Therapeutics shares, with 5.73% of its total shares outstanding invested in 2M RAPT Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools